[{"address1": "2 Bloor Street West", "address2": "Suite 903 7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "phone": "416 648 5555", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 67, "title": "Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 544510, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 67, "title": "Founder & Chief Development Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 352213, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hyman CA, CBV", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 85592, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.663, "open": 0.666, "dayLow": 0.666, "dayHigh": 0.666, "regularMarketPreviousClose": 0.663, "regularMarketOpen": 0.666, "regularMarketDayLow": 0.666, "regularMarketDayHigh": 0.666, "payoutRatio": 0.0, "beta": 1.697, "forwardPE": -3.947059, "volume": 508, "regularMarketVolume": 508, "averageVolume": 45079, "averageVolume10days": 47470, "averageDailyVolume10Day": 47470, "bid": 0.6608, "ask": 0.6769, "bidSize": 6000, "askSize": 7000, "marketCap": 55968004, "fiftyTwoWeekLow": 0.573, "fiftyTwoWeekHigh": 1.892, "allTimeHigh": 6.84, "allTimeLow": 0.151, "fiftyDayAverage": 0.7388, "twoHundredDayAverage": 0.76279, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 35694356, "profitMargins": 0.0, "floatShares": 60774078, "sharesOutstanding": 83409840, "sharesShort": 109389, "sharesShortPriorMonth": 278169, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.20822, "heldPercentInstitutions": 0.06317, "shortRatio": 0.77, "shortPercentOfFloat": 0.0069999998, "impliedSharesOutstanding": 84723748, "bookValue": 0.176, "priceToBook": 3.8125, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -13096000, "trailingEps": -0.11, "forwardEps": -0.17, "enterpriseToEbitda": -1.634, "52WeekChange": -0.5957831, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 0.671, "targetHighPrice": 6.0, "targetLowPrice": 2.5, "targetMeanPrice": 4.25, "targetMedianPrice": 4.25, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 20459000, "totalCashPerShare": 0.245, "ebitda": -21841000, "totalDebt": 162000, "quickRatio": 4.731, "currentRatio": 4.938, "debtToEquity": 1.106, "returnOnAssets": -0.44977, "returnOnEquity": -0.69804, "freeCashflow": -21871876, "operatingCashflow": -17710000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MDNAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "exchange": "OQX", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.2066389, "regularMarketPrice": 0.671, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1510583400000, "regularMarketChange": 0.008000016, "regularMarketDayRange": "0.666 - 0.666", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 45079, "fiftyTwoWeekLowChange": 0.09799999, "fiftyTwoWeekLowChangePercent": 0.17102964, "fiftyTwoWeekRange": "0.573 - 1.892", "fiftyTwoWeekHighChange": -1.221, "fiftyTwoWeekHighChangePercent": -0.64534885, "fiftyTwoWeekChangePercent": -59.578312, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.11, "epsForward": -0.17, "fiftyDayAverageChange": -0.067799985, "fiftyDayAverageChangePercent": -0.09177042, "twoHundredDayAverageChange": -0.09179002, "twoHundredDayAverageChangePercent": -0.12033459, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "shortName": "Medicenna Therapeutics Corp.", "corporateActions": [], "regularMarketTime": 1760054400, "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]